• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . The case fatality rate of COVID-19 during the Delta and the Omicron epidemic phase: A meta-analysis

tetano

Editor, Senior Moderator
J Med Virol


. 2023 Jan 24.
doi: 10.1002/jmv.28522. Online ahead of print.
The case fatality rate of COVID-19 during the Delta and the Omicron epidemic phase: A meta-analysis


Kisong Kim[SUP] 1 [/SUP], Kyuyeon Cho[SUP] 1 [/SUP], Junmin Song[SUP] 2 [/SUP], Masoud Rahmati[SUP] 3 [/SUP], Ai Koyanagi[SUP] 4 5 [/SUP], Seung Won Lee[SUP] 6 7 [/SUP], Dong Keon Yon[SUP] 8 9 [/SUP], Jae Il Shin[SUP] 10 [/SUP], Lee Smith[SUP] 11 [/SUP]



Affiliations

Abstract

Objective: As coronavirus variants are constantly occurring, we tried to understand more about the omicron and delta variants that have hit the world. We provided dynamic information on the case fatality rate (CFR) of the Omicron variant over time and to compare it with that of the Delta variant through meta-analysis.
Methods: 24 countries were selected by submission counts, submission dates, and confirmed cases. We defined the Delta or the Omicron epidemic period for individual countries as when each variant is over 90%. We further analyzed the Omicron period by dividing it into the initial plateau, increasing, and decreasing phases according to the number of newly confirmed daily cases. Finally, the meta-analysis examined the summary and between-study heterogeneity.
Results: The CFR of COVID-19 during the Omicron epidemic was lower than that during the Delta epidemic (odds ratio [OR]: 0.252, 95% confidence interval [CI] 0.205-0.309). The CFR of COVID-19 during the initial plateau phase of Omicron was higher than during other phases. (OR: 1.962, 95% CI 1.607 - 2.397). The CFR of COVID-19 during the increasing phase was lower than during the decreasing phases (OR: 0.412, 95% CI 0.342 - 0.498).
Conclusions: The Omicron variant had lower CFR compared to the Delta variant, and the initial plateau phase had higher CFR compared to the non-initial phases. These results can help establish global health policies for COVID-19 in the future. This article is protected by copyright. All rights reserved.

Keywords: COVID-19; Case Fatality Rate; Comparison; Delta Variant; Meta-analysis; Omicron Variant.
 
Back
Top Bottom